TIAA CREF INVESTMENT MANAGEMENT LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 127 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$4,739,000
-23.3%
496,753
-7.6%
0.00%
-40.0%
Q4 2018$6,175,000
-67.3%
537,871
-51.8%
0.01%
-16.7%
Q3 2018$18,910,000
+159.9%
1,115,652
+117.8%
0.01%
+20.0%
Q2 2018$7,275,000
-34.5%
512,306
-12.4%
0.01%
-37.5%
Q1 2018$11,106,000
-23.3%
584,538
-33.8%
0.01%
-20.0%
Q4 2017$14,487,000
+34.4%
883,382
+23.0%
0.01%
+42.9%
Q3 2017$10,777,000
+492.8%
718,482
+247.8%
0.01%
+600.0%
Q2 2017$1,818,000
+24.8%
206,563
-26.3%
0.00%0.0%
Q1 2017$1,457,000
+66.1%
280,112
-2.6%
0.00%0.0%
Q4 2016$877,000
-36.7%
287,541
-3.9%
0.00%0.0%
Q3 2016$1,386,000
-24.5%
299,321
-5.5%
0.00%0.0%
Q2 2016$1,835,000
-2.7%
316,851
+1.7%
0.00%0.0%
Q1 2016$1,885,000
-35.4%
311,547
-2.5%
0.00%
-50.0%
Q4 2015$2,916,000
+61.9%
319,3910.0%0.00%
+100.0%
Q3 2015$1,801,000
-51.4%
319,391
-4.5%
0.00%
-66.7%
Q2 2015$3,708,000
-35.2%
334,396
-8.4%
0.00%
-25.0%
Q1 2015$5,724,000
+3.5%
365,068
+0.4%
0.00%0.0%
Q4 2014$5,529,000
+35.4%
363,494
-4.0%
0.00%
+33.3%
Q3 2014$4,083,000
-30.2%
378,588
-1.2%
0.00%
-25.0%
Q2 2014$5,853,000
-9.3%
383,324
+7.4%
0.00%
-20.0%
Q1 2014$6,455,000
+43.2%
357,024
+10.0%
0.01%
+66.7%
Q4 2013$4,508,000
+40.6%
324,532
+6.0%
0.00%0.0%
Q3 2013$3,207,000
+31.0%
306,052
-2.4%
0.00%
+50.0%
Q2 2013$2,449,000313,5550.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders